Could a light cap ease autism symptoms?
NCT ID NCT05363982
First seen Jan 29, 2026 · Last updated May 25, 2026 · Updated 17 times
Summary
This study tested a new, non-invasive treatment called transcranial photobiomodulation (tPBM) for adults with autism spectrum disorder. Over 8 weeks, 41 participants received either the light therapy or a placebo to see if it was safe and could improve social and behavioral symptoms. The goal was to find a new way to help manage core autism challenges without medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.